LINK ALTERNATIF MBL77 - An Overview
Not all people with CLL call for therapy. Despite all modern innovations, the iwCLL nevertheless endorses watchful observation for individuals with asymptomatic disorder.86 This recommendation relies on at least two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).助成